Skip to main content
Celemics, Inc. logo

Celemics, Inc. — Investor Relations & Filings

Ticker · 331920 ISIN · KR7331920009 KO Manufacturing
Open in API
Filings indexed 189 across all filing types
Latest filing 2026-05-28 Regulatory Filings
Country KR South Korea
Listing KO 331920

About Celemics, Inc.

https://www.celemics.com/

Celemics, Inc. is a biotechnology company that develops and provides Next-Generation Sequencing (NGS) solutions for research and clinical applications. The company specializes in hybridization-based target enrichment technology, offering a comprehensive portfolio of products and services. This includes ready-to-use and customized NGS panels, whole exome sequencing kits, library preparation kits, modular accessories, and bioinformatics analysis services. Celemics' solutions support a wide range of fields, including oncology (somatic cancer, liquid biopsy), inherited diseases, pathogen analysis, pharmacogenomics, and immune repertoire profiling. A key focus is the development of end-to-end customized target enrichment panels, providing support from assay design and optimization to complete bioinformatics analysis. The company's proprietary technologies in probe design and molecular barcoding enable efficient analysis of diverse and challenging sample types.

Recent filings

Filing Released Lang Actions
주주총회소집결의 (임시주주총회)
Regulatory Filings Classification · 68% confidence The document is a notice of convening an extraordinary general meeting (임시주주총회) outlining date, location, record date, and board resolution details. It is a brief regulatory announcement under Korean disclosure rules, not the actual AGM materials or results, nor a detailed proxy statement, but a standard regulatory filing. As no more specific category (e.g., PSI) applies directly to a simple meeting-convening notice, it falls under the catch-all Regulatory Filings category.
2026-05-28 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 80% confidence The document is a brief regulatory announcement in Korean concerning the setting of a shareholder register closure period and record date for an extraordinary shareholder meeting. It does not contain substantive financial statements, proxy materials, voting results, or details of a report; rather it is a compliance notice filed under stock exchange rules. This aligns with the catch‐all “Regulatory Filings” category for miscellaneous exchange announcements (Code: RNS).
2026-05-28 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 93% confidence The document is a ‘주요사항보고서’ (material event report) filed with the Korean Financial Supervisory Service/Exchange announcing and detailing a decision on a 유상증자 (paid-in capital increase). It provides extensive specifics on the share issuance method, allotment, use of proceeds, timeline, and related board resolutions. This aligns with the ‘Share Issue/Capital Change’ category (SHA).
2026-05-21 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 95% confidence The document is titled “분기보고서” (Quarterly Report) covering the period 2026-01-01 to 2026-03-31 for 주식회사 셀레믹스. It contains detailed financial statements, business overview, sales, cost tables, market risk discussions, R&D activities, and other substantive interim period financial disclosures. This aligns exactly with the definition of an Interim/Quarterly Report. Q1 2026
2026-05-15 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 89% confidence The document is an amended '주요사항보고서(유상증자결정)' (Material Event Report – decision on paid‐in capital increase), detailing terms of a new share issuance, correction of the new shares listing date, issuance price, allocation, and related details. This is a direct announcement of a share issue/capital change, not merely a notice of publication or regulatory attestation. Therefore it falls under Share Issue/Capital Change (SHA).
2026-05-12 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is titled '주식등의 대량보유상황보고서(약식)' which translates to 'Report on Large Shareholding Status (Abbreviated)'. It details the ownership of shares exceeding 5% by a shareholder (Alphabet Partners) in the company 셀레믹스, including specifics on share counts, ownership percentages, changes in holdings, and related parties. The document is a regulatory filing related to disclosure of major shareholding changes as required by capital market laws. It is not an annual report, earnings release, or any other financial report but a notification of significant share ownership. This matches the definition of Major Shareholding Notification (Code: MRQ). The document length and content confirm it is the actual report, not just an announcement of a report publication.
2026-05-08 Korean

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.